← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 30, 2018Last known activity
Apr 8, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06891300Lead sponsorPhase 2/Phase 3Apr 8, 2025
- NCT06891300Sponsor investigatorPhase 2/Phase 3Apr 8, 2025
- NCT06809166Lead sponsorPhase 4Jul 4, 2024
- NCT06809166Sponsor investigatorPhase 4Jul 4, 2024
- NCT06431386OfficialN/AJun 30, 2024
- NCT06431386Lead sponsorN/AJun 30, 2024
- NCT06431386Sponsor investigatorN/AJun 30, 2024
- NCT05427500Reponsible party - principal investigatorEarly Phase 1Sep 1, 2022
- NCT05427500Overall official - principal investigatorEarly Phase 1Sep 1, 2022
- NCT05427500Lead sponsorEarly Phase 1Sep 1, 2022
- NCT03674671Overall official - principal investigatorPhase 3Sep 30, 2018
Details
- Last known activity
- Apr 8, 2025